Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/07/2012US8236767 Methods for treating inflammation using B7-H4 polypeptides and fragments thereof
08/07/2012US8236766 Uses of synthetic peptide amides
08/07/2012US8236765 Ganglioside epitopes for treating guillain-barre syndrome
08/07/2012US8236764 Methods for treating a hemostasis related disorder using activated forms of Factor V
08/07/2012US8236763 Administering N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide
08/07/2012US8236762 Peptide-cytotoxic conjugates
08/07/2012US8236761 C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
08/07/2012US8236760 Use of GLP-1 receptor agonists for the treatment of short bowel syndrome
08/07/2012US8236759 Glucagon-like peptide-1 (GLP-1); for treatment of diabetes, obesity, excessive appetite, insufficient satiety, and metabolic disorders; for converting liver stem/progenitor cells into functional pancreatic cells
08/07/2012US8236758 Method of treatment of diabestes or reduction in pancreatic beta-cells
08/07/2012US8236756 Prodrugs cleavable by CD26
08/07/2012US8236755 Opioid depot formulations
08/07/2012US8236754 Methods for improving the structure and function of arterioles
08/07/2012US8236753 RAP variants for drug delivery and methods of use thereof
08/07/2012US8236752 Pharmaceutical composition of nanoparticles
08/07/2012US8236751 Methods of increasing muscle mass using follistatin-like related gene (FLRG)
08/07/2012US8236750 Composition comprising a pulmonary surfactant and a TNF-derived peptide
08/07/2012US8236543 Methods of and compositions for inhibiting the proliferation of mammalian cells
08/07/2012US8236541 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/07/2012US8236510 Protein showing enhanced expression in cancer cells
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236494 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236355 COX-2 inhibitor
08/07/2012US8236353 Self-precipitating pharmaceutical formulations for the modified release of an active principle
08/07/2012US8236351 Tamper-resistant oral opioid agonist formulations
08/07/2012US8236344 Engineered proteins, and methods of making and using
08/07/2012US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
08/07/2012US8236323 Method to treat inflammation
08/07/2012US8236319 Cross-linkers and their uses
08/07/2012US8236303 Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
08/07/2012US8236302 Compositions and methods of using chondroitinase ABCI mutants
08/07/2012US8236301 Lumican proteoglycan in the diagnosis and treatment of atherosclerosis
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2461708C Delivery system for biological component
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2429384C Concatameric immunoadhesion
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2390057C High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam)
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/07/2012CA2286344C Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/04/2012CA2766684A1 Dual antagonism of endothelin type a and bradykinin b1 receptors for treating pain and preventing cartilage degradation
08/02/2012WO2012103520A1 Methods and compositions for modulating cyclophilin d
08/02/2012WO2012103415A1 Dosage regimen for the treatment of multiple disorders with botulinum toxins
08/02/2012WO2012103365A1 Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
08/02/2012WO2012103360A2 Wnt compositions and methods of use thereof
08/02/2012WO2012103343A1 Functional targeted brain endoskeletonization
08/02/2012WO2012103240A2 Receptor binding agents
08/02/2012WO2012103187A2 Methods of diagnosing and treating age-related macular degeneration
08/02/2012WO2012103019A2 Treating neuropsychiatric disorders
08/02/2012WO2012102900A1 Compositions and methods for providing or modulating sweet taste and methods of screening therefor
08/02/2012WO2012102820A1 System for defining energy field characteristics to illuminate nano-particles used to treat invasive agents
08/02/2012WO2012102753A2 Metalloproteinase oligopeptides and their therapeutic use
08/02/2012WO2012102625A2 Therapeutic composition
08/02/2012WO2012102529A2 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit
08/02/2012WO2012102308A1 Therapeutic agent and preventive agent for diabetes
08/02/2012WO2012102100A1 Sense-improving agent
08/02/2012WO2012101617A1 Antiviral peptides
08/02/2012WO2012101616A1 Antiviral peptides
08/02/2012WO2012101614A1 Antiviral peptides
08/02/2012WO2012101601A1 Glycogen synthase kinase-3 inhibitors
08/02/2012WO2012101599A2 Glycogen synthase kinase-3 inhibitors
08/02/2012WO2012101218A1 Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
08/02/2012WO2012101185A1 Urotensin ii, and urotensin ii receptor agonists for use in the symptomatic treatment of septic shock
08/02/2012WO2012101181A1 Compositions and methods for cell transplantation
08/02/2012WO2012101157A1 Human lactoferrin derived peptides and there use
08/02/2012WO2012100748A1 Glp-1 receptor agonist for treating pain
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012075549A3 Agents for increased resistance against oxidative stress conditions
08/02/2012WO2012075241A3 Protease degradable polypeptides and uses thereof
08/02/2012WO2012067481A3 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
08/02/2012WO2012064146A9 Anticancer composition containing gkn 1
08/02/2012WO2012061400A3 Method for reduction of free polysaccharide in polysaccharide-protein vaccines reactions using ion-exchange matrices
08/02/2012WO2012053856A3 Respiratory syncytial virus vaccine composition and method for preparing same
08/02/2012WO2012048291A3 Compositions and methods for inhibition of mmp:mmp-substrate interactions
08/02/2012WO2012036410A9 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
08/02/2012WO2011146527A3 Mammalian genes involved in infection
08/02/2012WO2011137245A3 Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
08/02/2012US20120197059 Ubiquitin interacting motif peptides as cancer therapeutics
08/02/2012US20120196810 Anionic polymer, polyion complex and ternary polymer composite using anionic polymer, and pharmaceutical composition
08/02/2012US20120196809 Use of icam-1 for prevention or treatment of neurological diseases
08/02/2012US20120196808 Peptidic Vasopressin Receptor Agonists
08/02/2012US20120196806 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid
08/02/2012US20120196805 Compositions and methods to control angiogenesis with cupredoxins
08/02/2012US20120196804 Glucagon analogs exhibiting physiological solubility and stability
08/02/2012US20120196803 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
08/02/2012US20120196802 Modified exendins and uses thereof
08/02/2012US20120196801 Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration
08/02/2012US20120196800 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
08/02/2012US20120196799 Amylin Family Peptides and Methods for Making and Using Them
08/02/2012US20120196798 Glp-1 analogues and their pharmaceutical salts and uses
08/02/2012US20120196797 Methods and Compositions for the Treatment of Gastrointestinal Disorders
08/02/2012US20120196796 Amylin family peptides and methods for making and using them
08/02/2012US20120196795 Novel exendin variant and conjugate thereof
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 3163